PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Nephrology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.\', \'Department of Nephrology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan. saito13@med.nagoya-u.ac.jp.\', \'Department of Emergency and Critical Care Medicine, Nagoya University Hospital, Nagoya, Japan.\', \'Department of Hospital Pharmacy, Nagoya University Hospital, Nagoya, Japan.\', \'Department of Clinical Laboratory, Nagoya University Hospital, Nagoya, Japan.\', \'Department of Infectious Diseases, Nagoya University Hospital, Nagoya, Japan.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s13730-020-00534-1
?:hasPublicationType
?:journal
  • CEN case reports
is ?:pmid of
?:pmid
?:pmid
  • 32940880
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Efficacy of favipiravir for an end stage renal disease patient on maintenance hemodialysis infected with novel coronavirus disease 2019.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all